214680.KQ
DRTECH Corporation
KOE · Healthcare · Medical - Specialties · KR
KRW 3,410.00
−1.45%Year over year
Reported trailing growth
- Revenue
- +11.8%
- EBITDA
- -91.3%
- EBIT
- -37.9%
- EPS
- +46.8%
- Free cash flow
- +48.4%
- Operating cash flow
- +61.7%
Forward estimates
Based on analyst estimates
- Revenue
- -54.8%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +9.1%
- EBITDA
- +34.5%
- EBIT
- -15.1%
- Net income
- -24.6%
- EPS
- +45.7%
- Free cash flow
- -3.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026